Q/C Technologies, Inc.
corporate_fare Company Profile
Q/C Technologies, Inc. (NASDAQ:QCLS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 13 items for QCLS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-21, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for QCLS spans SCHEDULE 13D/A, 8-K, 10-Q, 10-K/A.
Recent high-impact activity:
- PharmaCyte Reaches 49.99% Stake in Q/C Technologies Through Warrant Exchange
- Q/C Technologies Hands PharmaCyte a 49.99% Conversion Cap and Extends Series H Maturity to Sept 2027
- Q/C Technologies Q3 Loss Narrows to $0.9M; Discloses 4.98M-Share Warrant Exchange at $0.3101
- Q/C Technologies Receives Nasdaq $1.00 Bid Deficiency Notice, 180 Days to Cure
- Q/C Technologies Swings to Wider Loss, Names New CFO After License Termination
Financial Snapshot
Short Interest & Short Volume
6.16 days to coverFINRA reported short interest of 908,277 shares in QCLS as of the October 30, 2026 settlement, a 8.9% decrease from the prior period — about 6.2 days to cover at its recent average daily volume. On November 20, 2026, 12.9% of QCLS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.